Cerenome announces up to $20 million financing facility with royalty-based repayment
Cerenome said the capital will support continued CNSide® commercial scale-up and development. The initial funding tranche is provided at closing, with future tranches tied to milestones, and it expects forecasted cash runway.
Capital will support continued CNSide® commercial scale-up and developmentInitial tranche of funding provided at closing with future tranches linked to milestonesForecasted cash runway now into 2028HOUSTON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. NASDAQ:CNSY ("Cerenome" or the "Company"…